Therapeutic Area

Opioid Use Disorder

Therapeutic area intelligence for Opioid Use Disorder with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 1

Companies

Abbott →

Assets

FDA →

Pilot →

Recent signals(2)

ClinicalJune 19, 2026

Pilot Study on Deep Brain Stimulation for Opioid Use Disorder Initiated

A pilot study is underway to assess the safety and efficacy of deep brain stimulation targeting the nucleus accumbens in patients with treatment-refractory opioid use disorder.

RegulatoryJune 11, 2026

FDA Clears Bridge Device for Opioid Use Disorder Treatment; Efficacy Under Evaluation

The Bridge Device has received FDA clearance for the treatment of Opioid Use Disorder, emphasizing safety over efficacy.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Opioid Use Disorder →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.